Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 33.24
-1.26 (-3.65%)
At close: Mar 20, 2026
Redcare Pharmacy NV Revenue
In the year 2025, Redcare Pharmacy NV had annual revenue of 2.94B EUR with 24.06% growth. Redcare Pharmacy NV had revenue of 795.19M in the quarter ending December 31, 2025, with 17.78% growth.
Revenue
2.94B
Revenue Growth
+24.06%
P/S Ratio
0.23
Revenue / Employee
1.36M
Employees
2,163
Market Cap
668.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.94B | 570.30M | 24.06% |
| Dec 31, 2024 | 2.37B | 571.84M | 31.79% |
| Dec 31, 2023 | 1.80B | 594.41M | 49.35% |
| Dec 31, 2022 | 1.20B | 144.03M | 13.58% |
| Dec 31, 2021 | 1.06B | 92.26M | 9.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.10B |
| Gerresheimer AG | 2.25B |
| Carl Zeiss Meditec AG | 2.20B |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.95B |
| Dermapharm Holding SE | 1.17B |